Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014861

EVP & Chief Commercial Officer sold 11,239 shares at $3.03 ($34,045)

  • EVP & Chief Commercial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cheng Sohanya Roshan · EVP & Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-28 Grant or award : show line 1 in the form +100,000 221,926 D
2023-03-01 Sale : show line 2 in the form −11,239 $3.03 $34,045 210,687 D
Open-market sales · 11,239 sh · avg $3.03 · $34,045
Loading xslF345X03/doc4.xml…